Lactobacillus rhamnosus MP108

1 of 17 products in this brand
Lactobacillus rhamnosus MP108 is a product whose strain origin is isolated from healthy infants' intestines with no microbial domestication or mutation process. Its applications encompass intestine health, immune health, and oral health. Labeling claims highlight non-toxicity, non-hazardousness, and biodegradability. End uses include infant formula, dietary supplements, and functional foods.

Ingredient Name: Lactobacillus Rhamnosus

Functions: Probiotic

Labeling Claims: Biodegradable, Halal, Kosher, Non-Hazardous, Non-Toxic

Certifications & Compliance: EFSA (European Food Safety Authority) Certified, FDA Compliant

Benefit Claims (Health): Promotes Healthy Gut Microflora, Supports Immune System

Ask Pharm-Rx Chemical Corp. Questions

Mark Bostel avatar
Message our experts with questions
Mark Bostel avatar

Mark Bostel

Please reach out to me with any questions, I am happy to assist you in finding the right product or learning more about our storefront

Enhanced TDS

Identification & Functionality

Features & Benefits

Applications & Uses

Properties

Physical Form
Appearance
White to light brown color powder
Microbiological Values
ValueUnitsTest Method / Conditions
Yeast & Molds Countmax. 100cfu/gTaiwan Food and Drug Administration ( TFDA ) method
Staphylococcus AureusNegativecfu/gTaiwan Food and Drug Administration ( TFDA ) method
SalmonellaNegativecfu/gTaiwan Food and Drug Administration ( TFDA ) method
Listeria MonocytogenesNegativecfu/gTaiwan Food and Drug Administration ( TFDA ) method
Eschericha ColiNegativecfu/gTaiwan Food and Drug Administration ( TFDA ) method
ColiformsNegativecfu/gTaiwan Food and Drug Administration ( TFDA ) method
Specifications
ValueUnitsTest Method / Conditions
Water Activitymax. 0.25awTaiwan Food and Drug Administration ( TFDA ) method
Viable Cell Countsmax. 3.0 × 10¹¹cfu/gTaiwan Food and Drug Administration ( TFDA ) method
Moisture Contentmax. 7%Taiwan Food and Drug Administration ( TFDA ) method
Composition
NO.CompositionContent (%)
1Lactobacillus rhamnosus MP108100%
 Total100%

Regulatory & Compliance

Certifications & Compliance
FDA Disclaimer

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Technical Details & Test Data

Product Characteristics

High Gastric Acid and Bile Tolerance:

MP108 remained high bioavailability in the simulated environment with Gastric Acid and Bile for 7 hours.Bioflag Lactobacillus rhamnosus MP108 - Product Characteristics - 1

Strong Colonization on Caco-2 Intestine Cells:

MP108 highly adheres to Caco-2 intestine cells

Bioflag Lactobacillus rhamnosus MP108 - Product Characteristics - 1

Improve Diarrhea and Constipation:

Infants and young children suffering diarrhea (>3 times a day) were given MP108 ( 5×109CFU/day) (blue bar) or MP108 probiotic combined with antibiotics (orange bar) for 7 days, and the result shows that MP108 can improve the symptoms of diarrhea.

Bioflag Lactobacillus rhamnosus MP108 - Product Characteristics - 1

80 subjects with severe diarrhea ( Less than 3 times of defecation) took MP108 ( 10 billion cfu/day), administration 4 weeks.

Bioflag Lactobacillus rhamnosus MP108 - Product Characteristics - 1

Improve Allergic Symptoms:

Clinical Trial : 59 subjects aged 6-13 years old with Chronic rhinitis took MP108 ( 5 billion cfu/day) with antihistamine for the first 30 days, and stop taking antihistamine during the following 60 days, but MP108 alone.

Bioflag Lactobacillus rhamnosus MP108 - Product Characteristics - 1

Improve Atopic Dermatitis:

Clinical Trial: 66 infants aged 4-48 months with dermatitis took MP108 (5 billion cfu/day) and applied topical corticosteroids. Administration 8 weeks.

Bioflag Lactobacillus rhamnosus MP108 - Product Characteristics - 1

 Clinical Study: on 62 infants and young children aged 4-48 months and diagnosed with atopic dermati with a Scoring of Atopic Dermatitis (SCORAD) ≥ 15, conducted for 8 weeks, with 32 subjects in control group (placebo) and 30 subjects in probiotics group (MP108) (* p < 0.05 vs. control group):

MP108 could improve atopic dermatitis:

Bioflag Lactobacillus rhamnosus MP108 - Product Characteristics - 1

MP108 could reduce the intensity of atopic dermatitis

Bioflag Lactobacillus rhamnosus MP108 - Product Characteristics - 1

Clinical Study on 59 children aged 6-13 years and diagnosed with allergic rhinitis for > 1 year with medium to severe symptoms, conducted for 90 days, with administration of antihistamine therapy and MP108 capsules during the first 30 days and MP108 capsules only during the other 60 days:

MP108 helps improve symptoms of allergic rhinitis

Bioflag Lactobacillus rhamnosus MP108 - Product Characteristics - 1

MP108 helps reduce nasal airway resistance

Bioflag Lactobacillus rhamnosus MP108 - Product Characteristics - 1

 

Packaging & Availability

Packaging Type
Packaging Information

1kg a bag with nitrogen filling and vacuum packing.

Storage & Handling

Shelf Life
24 months